Millan, Febriel Jane B.

HRN: 15-98-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2025
CEFUROXIME 1.5GM (VIAL)
11/30/2025
12/01/2025
IV
1.5 G
Every 8 Hrs
S/P NSVD With RMLE, Inc WBC
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines